ASCO asks the oncology field’s hard AI question: are we actually ready for routine care?
A new ASCO Post overview captures oncology’s central AI tension: the technology is already useful in pockets of care, but broad clinical deployment still faces evidence, workflow, and trust gaps. The piece is significant because it frames cancer AI not as a future promise, but as a present implementation problem.
Artificial intelligence in oncology has moved beyond speculative demos. The more important question now is where it is mature enough to influence diagnosis, prognosis, and treatment in everyday practice. The ASCO Post’s framing matters because it reflects how leading cancer clinicians are increasingly evaluating AI: less by technical novelty and more by clinical utility, reproducibility, and fit with care delivery.
That shift is healthy for the field. Oncology is especially vulnerable to overclaiming because its data are rich, its decisions are high-stakes, and its unmet needs are enormous. Models can look impressive in retrospective datasets yet still fail to improve outcomes when inserted into tumor boards, radiology queues, pathology workflows, or treatment planning. Asking "are we there yet?" forces a distinction between performance metrics and deployment readiness.
The article also highlights a broader market reality: the most durable oncology AI applications are likely to be narrow, workflow-aware, and measurable. Tools that help identify overlooked findings, prioritize cases, standardize image interpretation, or support treatment stratification may scale faster than systems claiming to "transform cancer care" end to end. Hospitals and cancer centers increasingly want evidence that a tool saves time, reduces misses, or changes management, not just that it matches expert labels.
In that sense, oncology AI is entering a more mature era. The winning systems will probably be those that survive contact with clinical operations, reimbursement constraints, and medico-legal scrutiny. The field is not at the finish line, but it is finally asking the right implementation questions.